Abstract:Background: Magnetic fluid hyperthermia is a kind of technology for treating tumors based on nanotechnology. It is suitable to various types of tumors. The purpose of this study was to prepare carboplatin-Fe@C-loaded chitosan nanoparticles with Fe@C as a magnetic core and to investigate efficacy of hyperthermia combined with chemotherapy for transplanted liver cancer in rats.Methods: Fe@C nanopowder was treated with dilute hydrochloric acid to prepare Fe@C nanocage. Carboplatin-Fe@C-loaded chitosan nanoparticles were prepared by reverse microemulsion method with the nanocages as the magnetic cores, chitosan as the matrix. The shape, size, drug-loading rate, and in vitro cumulative release of the nanoparticles were observed and heat product under high frequency alternating electromagnetic field in vitro was explored. Eighty rats with transplanted liver cancer were randomly divided into 4 groups (group A: control group, group B: free carboplatin group, group C: nanoparticles with static magnetic field group, and group D: nanoparticles with static field and alternating magnetic field). Drug was injected into the hepatic artery. The therapeutic effect of hyperthermia combined with chemotherapy for tumor, toxicity and rat survival time were observed.Results: Carboplatin-Fe@C-loaded chitosan nanoparticles were spherical in shape with an average size of (207 +/- 21) nm and high saturation magnetization. The drug-loading rate of the nanoparticles was 11.0 +/- 1.1%. The cumulative release percentage of carboplatin-Fe@C-loaded chitosan nanoparticles in vitro at different point time phase of 24 h, 48 h, 72 h, 96 h and 120 h were 51%, 68%, 80%, 87% and 91%, respectively. With an increase in carboplatin-Fe@C-loaded chitosan nanoparticle concentration and magnetic field strength, the heating rate and constant temperature of carboplatin-Fe@C-loaded chitosan nanoparticles dispersed in physiological saline were increased in an alternating magnetic field. In vivo experiments showed that after particle injection, tumor temperature reached 42.6 degrees +/- 0.2 degrees C within 10 min in the alternating magnetic field; and the temperatures in the right hepatic lobes and the rectum were significantly lower than in the tumor and the constant temperature could last up to 30 min. The inhibition ratio of tumor weight in group D was significantly enhanced, no obviously toxic and side-effect occurred and survival time was prolonged.Conclusion: Carboplatin-Fe@C-loaded chitosan nanoparticles possess good magnetic targeting and heat production properties. They can target liver cancer tissue by static magnetic field, and with the application of alternating magnetic field, effectively raise tumor tissue temperature and facilitate tumor apoptosis. The combination of chemotherapy and magnetic materials into nanoparticles as described herein demonstrates promising efficacy.

Fe-loaded liquid-solid phase inversion PLGA implants for in situ magnetic hyperthermal ablation of in vitro pork liver

Fe-loaded liquid-solid phase inversion PLGA implantation for magnetic hyperthermal ablation of SKOV3 human ovarian cancer in situ of nude mice

The Enhanced HIFU-induced Thermal Effect Via Magnetic Ultrasound Contrast Agent Microbubbles.

PLGA-NdFeB-Fe3O4 implant for magnetic hyperthermia of mice bearing breast cancer

Highly efficient magnetic hyperthermia ablation of tumors using injectable polymethylmethacrylate–Fe3O4

Injectable ferrimagnetic silk fibroin hydrogel for magnetic hyperthermia ablation of deep tumor

Injectable and Thermally Contractible Hydroxypropyl Methyl Cellulose/fe3o4 for Magnetic Hyperthermia Ablation of Tumors

Superparamagnetic PLGA–iron oxide microspheres as contrast agents for dual-imaging and the enhancement of the effects of high-intensity focused ultrasound ablation on liver tissue

Magnetic and injectable Fe-doped liquid metals for controlled movement and photothermal/electromagnetic therapy

A smart, phase transitional and injectable DOX/PLGA-Fe implant for magnetic-hyperthermia-induced synergistic tumor eradication

Evaluation of superparamagnetic iron oxide-polymer composite microcapsules for magnetic resonance-guided high-intensity focused ultrasound cancer surgery

Injectable Magnetic Liquid-solid Phase Transition Material for MR Imaging and Low-temperature Magnetocaloric Therapy of Osteosarcoma

Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe3o4/Calcium Phosphate Cement

Preparation of Carboplatin-Fe@c-loaded Chitosan Nanoparticles and Study on Hyperthermia Combined with Pharmacotherapy for Liver Cancer

Injectable PLGA/Fe3O4 implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumor

Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells

Magnetic Arterial Embolization Hyperthermia Mediated by Carbonyl Iron Powder for Liver Carcinoma

Injectable Nonmagnetic Liquid Metal for Eddy‐Thermal Ablation of Tumors under Alternating Magnetic Field

Minimally Invasive Delivery of Percutaneous Ablation Agent Via Magnetic Colloidal Hydrogel Injection for Treatment of Hepatocellular Carcinoma

Intermittent Time-Set Technique Controlling the Temperature of Magnetic-Hyperthermia-ablation for Tumor Therapy

Therapeutic Effect of Fe2o3 Nanoparticles Combined with Magnetic Fluid Hyperthermia on Cultured Liver Cancer Cells and Xenograft Liver Cancers